Literature DB >> 7685433

[Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma].

Y Okubo1, K Nakazawa.   

Abstract

Two cases of non-Hodgkin's lymphoma suffered from acute respiratory failure. Both patients were treated with MACOP-B therapy, and received recombinant granulocyte-colony stimulating factor (rG-CSF) during the myelosuppression. They had fever and severe hypoxemia several days after 11 and 12-week's treatment, respectively. The chest X-ray films revealed diffuse fine granular shadows in bilateral lung fields. The number of white blood cells had rapidly increased when the shadows appeared. These cases suggested the possibility that rG-CSF, or the rapid increase of white blood cells, might induce interstitial pneumonia.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685433

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN： 0485-1439


  5 in total

1.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

2.  Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96.

Authors:  N Niitsu; S Iki; K Muroi; S Motomura; M Murakami; H Takeyama; A Ohsaka; A Urabe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Granulocyte Colony-stimulating Factor-induced Aortitis with Lung Injury, Splenomegaly, and a Rash During Treatment for Recurrent Extraosseous Mucinous Chondrosarcoma.

Authors:  Takahiro Kametani; Yuichiro Otani; Toshikazu Ohigashi; Tadahiko Kubo; Tomohiko Sakuda; Daisuke Furuta; Yayoiko Ito; Yuya Shigenobu; Masaki Kakimoto; Akihiro Kawahara; Yuka Kikuchi; Tomoki Kobayashi; Daisuke Miyamori; Nobusuke Kishikawa; Keishi Kanno; Masanori Ito
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

4.  Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.

Authors:  N Yokose; K Ogata; H Tamura; E An; K Nakamura; K Kamikubo; S Kudoh; K Dan; T Nomura
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

5.  Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery.

Authors:  In Kyoung Kim; Chin Kook Rhee; Chang Dong Yeo; Hyeon Hui Kang; Dong Gun Lee; Sang Haak Lee; Jin Woo Kim
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.